CNR Institutional Research Information System

TROVATO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 931
NA - Nord America 343
SA - Sud America 197
EU - Europa 150
AF - Africa 15
OC - Oceania 4
Totale 1.640
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 365
US - Stati Uniti d'America 319
CN - Cina 252
BR - Brasile 159
HK - Hong Kong 92
VN - Vietnam 70
KR - Corea 68
IT - Italia 36
FI - Finlandia 23
IN - India 17
AR - Argentina 16
GB - Regno Unito 16
DE - Germania 14
FR - Francia 12
NL - Olanda 12
JP - Giappone 11
IL - Israele 8
MX - Messico 8
AT - Austria 7
CA - Canada 7
PY - Paraguay 6
BD - Bangladesh 5
EC - Ecuador 5
ID - Indonesia 5
RU - Federazione Russa 5
ZA - Sudafrica 5
CO - Colombia 4
PK - Pakistan 4
TR - Turchia 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
CL - Cile 3
ES - Italia 3
IQ - Iraq 3
KZ - Kazakistan 3
MA - Marocco 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
SE - Svezia 3
TJ - Tagikistan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CH - Svizzera 2
DZ - Algeria 2
IE - Irlanda 2
KG - Kirghizistan 2
KH - Cambogia 2
MN - Mongolia 2
PA - Panama 2
VE - Venezuela 2
BB - Barbados 1
BE - Belgio 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 1.640
Salva come PNG Salva come JPEG
Città #
Singapore 222
Hefei 133
Santa Clara 128
Hong Kong 91
Seoul 67
Beijing 46
Dallas 26
Ashburn 22
Ho Chi Minh City 22
Los Angeles 20
Marigliano 19
Hanoi 17
Helsinki 16
San Jose 14
São Paulo 14
Avellino 9
New York 9
Lappeenranta 7
Minamishinagawa 7
Rio de Janeiro 6
Bengaluru 5
Denver 5
Frankfurt am Main 5
Atlanta 4
Brasília 4
Buffalo 4
Düsseldorf 4
Hyderabad 4
Lauterbourg 4
Portsmouth 4
Santo André 4
Tashkent 4
Tokyo 4
Asunción 3
Belo Horizonte 3
Biên Hòa 3
Boardman 3
Curitiba 3
Dushanbe 3
Guarulhos 3
Ninh Bình 3
Seattle 3
Stockholm 3
São Bernardo do Campo 3
Algiers 2
Almaty 2
Alvorada 2
Amsterdam 2
Ankara 2
Barbacena 2
Bishkek 2
Boston 2
Brooklyn 2
Buenos Aires 2
Bắc Ninh 2
Casandrino 2
Chapecó 2
Chennai 2
Chicago 2
Ciudad del Este 2
Cuiabá 2
Da Nang 2
Falkenstein 2
Goiânia 2
Haiphong 2
Johannesburg 2
Jundiaí 2
London 2
Luanda 2
Marília 2
Mexico City 2
Montreal 2
Naples 2
Orem 2
Paulo Afonso 2
Phnom Penh 2
Poplar 2
Quận Phú Nhuận 2
Riyadh 2
Salvador 2
Santa Luzia 2
Santiago 2
Solânea 2
São José dos Pinhais 2
Teresina 2
Thái Bình 2
Tirana 2
Ulan Bator 2
Vienna 2
Zurich 2
Abu Dhabi 1
Afragola 1
Aguaí 1
Ahmedabad 1
Ajdovščina 1
Alcobaça 1
Ambato 1
Amman 1
Araguari 1
Araruama 1
Totale 1.085
Salva come PNG Salva come JPEG
Nome #
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 99
Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection 82
Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation 78
HIV Vaccination: A Roadmap among Advancements and Concerns. 76
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants 65
Review HIV Vaccination: A Roadmap among Advancements and Concerns 62
Alum and Squalene-Oil-in-Water Emulsion enhance the titer and avidity of Anti-Ab antibodies induced by Multimeric Protein Antigen (i-11)E2, preserving the IgG1-skewed isotype distribution 61
Multimeric scaffolds displaying the IV-1 envelope Mper- specific antibodies and cross-neutralizing antibodies when co-immunized with gp 160 58
Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay 55
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 52
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant 52
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 46
The molecular basis of covid-19 pathogenesis, conventional and nanomedicine therapy 45
Distinct Features of Germinal Center Reactions in Macaques Infected by {SIV} or Vaccinated with a T-Dependent Model Antigen 41
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 41
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 36
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 34
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 34
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 33
E2 multimeric scaffold for vaccine formulation: transcriptome analysis of pulsed dendritic cells and immune response by intranasal delivery. 33
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 32
Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-a? antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution 30
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 29
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 28
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 27
Anti-beta amyloid antibodies induced by a multimeric protein antigen formulated in alum, squalene or without adjuvant. 25
E2 display as a novel vaccine approach to induce HIV-1 neutralizing antibodies. 25
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFN³ production by CD4+ T cells 24
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 24
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 24
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform. 24
Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-A? antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution 23
Design and characterizationof mimotope of the HIV-1 gp120 Bridging Sheet 22
Novel Antigen Display System To Elicit Anti- V3 Region/Membrane Proximal External Regjion HIV - 1 Neutralizing Antibodies 21
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 21
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 21
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 21
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 20
Delivery strategies for novel vaccine formulations 20
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 20
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 20
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 19
E2 display as a novel vaccine approach to induce HIV-1 neutralizing antibodies 18
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 17
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 17
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 16
Novel Antigen Display System To Elicit Anti-V3 Region/Membrane Proximal External Region HIV-1 Neutralizing Antibodies 16
Totale 1.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.985
article - articoli 3.406
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 0 0 32 3
2024/2025746 3 4 54 20 127 43 4 85 34 19 187 166
2025/2026906 77 138 157 215 225 70 24 0 0 0 0 0
Totale 1.687